Cumberland Pharmaceuticals
CPIX
47 hedge funds and large institutions have $27M invested in Cumberland Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 3 closing their positions.
2% less funds holding
Funds holding: 48 → 47 (-1)
10% less capital invested
Capital invested by funds: $30.1M → $27M (-$3.08M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$247K |
| 2 |
Renaissance Technologies
New York
|
+$106K |
| 3 |
SIM
Spark Investment Management
New York
|
+$37K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.3K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$384K |
| 2 |
Norges Bank
Oslo,
Norway
|
-$108K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$85.5K |
| 4 |
RA
Royce & Associates
New York
|
-$84K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$69.1K |
CPIX Hedge Fund Activity: Q4 2015 in Review
47 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2015, worth a combined $27M — down 10% from $30.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPIX and 2 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 11 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $247K. The largest seller was Ariel Investments, cutting an estimated $384K.
- 47 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2015, down from 48 in Q3 2015.
- Funds reported $27M of Cumberland Pharmaceuticals stock for Q4 2015, down 10% quarter-over-quarter.
- 2 funds opened new Cumberland Pharmaceuticals positions in Q4 2015 and 3 closed out, a net change of -1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q4 2015 was Bridgeway Capital Management, an estimated $247K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2015 was Ariel Investments, an estimated $384K sold.
Based on aggregated 13F filings for Q4 2015.